Log in Request a Demo

US Pharma & Biotech Pulmonology - PPC Market Share Analysis February 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pulmonology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
cvs.com 18.79
breztri.com 14.8
breztrihcp.com 10.25
dupixenthcp.com 9.53
dupixent.com 5.02
tezspire.com 4.32
walgreens.com 3.92
boehringer-ingelheim.com 3.52
pulmonx.com 3.15
copdfoundation.org 2.83
others 23.87

Copyright © Adthena. All rights reserved.

In the PPC landscape, CVS leads with 18.79% click share, followed by Breztri.com at 14.8%. ‘Others’ collectively hold a significant 23.87%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date breztri.com cvs.com dupixenthcp.com breztrihcp.com tezspire.com dupixent.com boehringer-ingelheim.com pulmonx.com airsupra.com airsuprahcp.com
2025/01/01 18.74% 7.36% 4.46% 6.36% 9.27% 4.26% 6.82% 1.02% 5.8% 6.37%
2025/01/02 27.11% 7.66% 2.12% 24.18% 2.34% 6.77% 0.08% 0.86% 2.09% 0.39%
2025/01/03 5.81% 26.53% 4.47% 4.06% 7.56% 6.04% 2.6% 1.82% 3.62% 3.54%
2025/01/04 7.7% 2.02% 15.73% 5.62% 5.71% 2% 23.14% 0.61% 4.81% 9.3%
2025/01/05 23.74% 3.66% 5.68% 40.91% 4.41% 1.38% 0.06% 0.83% 0.41% 0.29%
2025/01/06 7.59% 2.38% 21.31% 7.29% 5.17% 19.81% 12.62% 0.62% 1.38% 6.64%
2025/01/07 17.08% 2.63% 16.72% 14.75% 4.04% 4% 0.08% 0.33% 4.08% 5.94%
2025/01/08 13.78% 1.31% 2.72% 13.74% 6.85% 21.03% 2.85% 11.96% 2.1% 3.52%
2025/01/09 21.13% 3.95% 5.9% 16.49% 4.47% 9.19% 2.73% 0.57% 2.68% 6.56%
2025/01/10 6.69% 3.68% 5.07% 4.07% 9.64% 3.02% 6.72% 14.01% 1.94% 4.76%
2025/01/11 27.28% 0.93% 12.17% 22.68% 6.75% 5.51% 3.87% 1.3% 1.37% 5.74%
2025/01/12 13.57% 4.52% 4.54% 9.14% 8.83% 9.67% 3.31% 1.4% 7.84% 3.71%
2025/01/13 4.17% 12.01% 16.41% 2.11% 2.01% 1.26% 4.22% 18.93% 0.22% 3.85%
2025/01/14 15.26% 15.07% 18.1% 11.89% 7.9% 3.25% 4.01% 1.71% 2.16% 1.12%
2025/01/15 18.46% 1.05% 2.18% 17.38% 5.48% 16.82% 2.28% 9.56% 1.68% 2.82%
2025/01/16 21.02% 3.94% 5.87% 16.41% 4.45% 9.15% 2.72% 0.56% 2.66% 6.53%
2025/01/21 5.43% 2.42% 7.29% 4.53% 8.51% 0.29% 0.16% 3% 0.59% 0.37%
2025/01/22 1.46% 26.43% 34.4% 0.52% 3.5% 0.3% 0.11% 1.48% 1.11% 0.18%
2025/01/23 7.02% 4.45% 19% 3.39% 6.14% 4.8% 3.57% 0.97% 4.69% 3.29%
2025/01/24 1.2% 3.15% 7.87% 0.66% 8.91% 1.61% 0.02% 2.28% 3.2% 0.8%
2025/01/25 13.73% 10.87% 12.51% 11.4% 7.02% 1.08% 0.01% 1.22% 4.76% 0.05%
2025/01/26 35.26% 23.14% 6% 0.09% 7.06% 3.01% 0.01% 2.8% 5.4% 0.36%
2025/01/27 5.76% 12.39% 8.3% 0.46% 9.96% 2.9% 1.87% 5.07% 7.56% 0.15%
2025/01/28 31.44% 5.18% 9.33% 0.14% 10.2% 0.32% 0.03% 5.18% 1.11% 6.46%
2025/01/29 3.41% 9.13% 21.55% 2.13% 7.55% 4.49% 0.01% 3.07% 3.59% 3.14%
2025/01/30 19.87% 4.59% 13.09% 10.17% 8.63% 3.52% 0.01% 1.01% 1.25% 1.66%
2025/01/31 22.28% 18.14% 13.03% 9.61% 8.53% 2.61% 1.7% 1.4% 1.26% 0.95%

Copyright © Adthena. All rights reserved.

Breztri.com led January with fluctuating spend, peaking at 35.26% on the 26th. Cvs.com and dupixenthcp.com showed consistent activity, while breztrihcp.com and pulmonx.com had sporadic spikes. The month ended with diverse spend patterns.

Market Exposure

Competitor Count for US Pharma & Biotech Pulmonology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/01/01 98
2025/01/02 94
2025/01/03 91
2025/01/04 84
2025/01/05 82
2025/01/06 92
2025/01/07 93
2025/01/08 91
2025/01/09 92
2025/01/10 105
2025/01/11 85
2025/01/12 90
2025/01/13 90
2025/01/14 90
2025/01/15 91
2025/01/16 92
2025/01/21 89
2025/01/22 91
2025/01/23 79
2025/01/24 82
2025/01/25 71
2025/01/26 68
2025/01/27 70
2025/01/28 66
2025/01/29 85
2025/01/30 92
2025/01/31 86

Copyright © Adthena. All rights reserved.

January saw fluctuating advertiser numbers, peaking at 105 on January 10th, then declining to 66 by January 28th, before ending at 86.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pulmonology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
cvs.com 14.19%
copdfoundation.org 7.77%
allergyasthmanetwork.org 3.01%
resphealth.org 2.78%
walgreens.com 2.69%
airsuprahcp.com -2.05%
pulmonx.com -4.36%
boehringer-ingelheim.com -5.33%
dupixent.com -6.83%
breztrihcp.com -8.36%

Copyright © Adthena. All rights reserved.

CVS.com surged with a 14.19% click share increase, while copdfoundation.org rose by 7.77%. Conversely, breztrihcp.com plummeted by 8.36%, and dupixent.com fell by 6.83%.

Campaign Efficiency

US Pharma & Biotech Pulmonology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date breztri.com cvs.com dupixenthcp.com breztrihcp.com tezspire.com walgreens.com dupixent.com pulmonx.com airsuprahcp.com copdfoundation.org
2025/01/01 23.16% 13.07% 1.49% 5.14% 8.09% 7.28% 0.99% 0.53% 5.71% 0%
2025/01/02 23.45% 9.71% 0.4% 23.54% 0.92% 0.74% 3.56% 0.36% 0.16% 0%
2025/01/03 2.71% 37% 1.35% 2.62% 5.45% 2.87% 3.2% 0.81% 3.64% 0%
2025/01/04 7.2% 3.61% 23.8% 6.01% 6% 0.67% 0.67% 0.33% 7.75% 0%
2025/01/05 23.45% 4.89% 1.24% 46.41% 3.61% 1.72% 0.64% 0.41% 0.13% 0%
2025/01/06 7.46% 3.14% 24.87% 7.97% 3.75% 0.82% 19.44% 0.32% 3.9% 0%
2025/01/07 15.58% 2.3% 15.19% 15.17% 2.19% 4.25% 0.62% 0.11% 4.2% 0%
2025/01/08 18.23% 1.35% 0.71% 19.27% 9.35% 1.05% 16.34% 8.3% 2.09% 0%
2025/01/09 25.92% 5.69% 1.74% 23.32% 2.9% 2.09% 1.85% 0.3% 7.34% 0%
2025/01/10 4.54% 3.91% 1.33% 2.45% 15.25% 3.94% 0.66% 12.55% 4.07% 0.06%
2025/01/11 29.7% 1.13% 13.46% 28.62% 6.04% 0.83% 2.1% 0.76% 4.35% 0%
2025/01/12 10.09% 7.69% 1.17% 7.61% 7.41% 3.76% 5.6% 0.73% 2.61% 0%
2025/01/13 2.58% 12.58% 18.15% 1.62% 1.14% 4.18% 0.16% 17.91% 3.22% 0.14%
2025/01/14 9.59% 14.03% 10.4% 9.16% 2.82% 2.3% 0.33% 0.52% 0.95% 9.32%
2025/01/15 18.23% 1.35% 0.71% 19.27% 9.36% 1.05% 16.34% 8.3% 2.09% 0%
2025/01/16 25.91% 5.69% 1.74% 23.32% 2.91% 2.09% 1.85% 0.3% 7.34% 0%
2025/01/21 5.23% 4.57% 1.56% 4.9% 5.45% 0.96% 0.03% 1.75% 0.28% 63.71%
2025/01/22 0.52% 24.63% 37.15% 0.23% 1.63% 5.8% 0.09% 0.67% 0.1% 0.1%
2025/01/23 5.28% 3.18% 18.77% 2.34% 3.67% 2.33% 1.89% 0.5% 2.3% 14.81%
2025/01/24 0.41% 3.71% 1.42% 0.27% 4.31% 1.2% 0.21% 1.01% 0.42% 0%
2025/01/25 11.14% 7.92% 10.31% 10.75% 3% 3.14% 0.38% 0.46% 0.02% 0%
2025/01/26 40.4% 25.85% 1.04% 0.03% 5.03% 5.48% 2.68% 1.33% 0.23% 0.1%
2025/01/27 5.68% 26.39% 2.98% 0.2% 7.77% 9.57% 2.2% 3.47% 0.1% 0%
2025/01/28 40.57% 9.47% 1.94% 0.05% 5.65% 9.52% 0.02% 2.86% 6.05% 0.21%
2025/01/29 3.34% 10.18% 21.08% 1.92% 6.07% 7.63% 3.93% 1.88% 3% 16.06%
2025/01/30 22.91% 6.41% 12.49% 12.22% 6.69% 2.67% 1.42% 0.56% 1.12% 0.36%
2025/01/31 26.44% 18.64% 13.46% 12.55% 5.97% 5.54% 1.09% 0.76% 0.63% 0.05%

Copyright © Adthena. All rights reserved.

Breztri.com saw fluctuating impressions, peaking at 40.57% on January 28. Cvs.com had a notable rise to 26.39% on January 27. Dupixenthcp.com spiked to 37.15% on January 22. Breztrihcp.com’s highest was 46.41% on January 5. Tezspire.com remained steady, peaking at 15.25% on January 10. Walgreens.com had a modest peak of 9.57% on January 27. Dupixent.com saw a high of 19.44% on January 6. Pulmonx.com peaked at 17.91% on January 13. Airsuprahcp.com had a high of 7.75% on January 4. Copdfoundation.org’s impressions surged to 63.71% on January 21.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    What Are The Symptoms Of COPD? - Review The 4 Stages Of COPD Prescription treatment website

    Find Out How You May Be Able To Reduce Flare-Ups & Breathe Better With This COPD Inhaler.

  2. 2
    Symptoms Of An Exacerbation - COPD Exacerbation Info Prescription treatment website

    Exacerbations Can Present Significant Dangers. Are You Ready To Help Protect Against Them?

  3. 3
    What Is COPD? - Signs And Symptoms Of COPD https://www.copdfoundation.org

    COPD Is Currently An Incurable Disease, But There Are Things You Can Do To Breathe Better.

  4. 4
    A COPD Treatment Option - COPD Lung Disease Prescription treatment website

    Discover A Treatment Option That May Help Reduce Exacerbations. Treating Patients.

  5. 5
    Help Finding An Asthma Doctor - Official Patient Site Prescription treatment website

    Find An Asthma Specialist That Can Help You Control Severe Asthma And Identify Triggers.

Copyright © Adthena. All rights reserved.

In the competitive landscape of COPD and asthma treatment, Breztri and Dupixent stand out with compelling narratives. Breztri’s ads focus on reducing flare-ups and protecting against exacerbations, while Dupixent highlights treatment options for lung disease. Meanwhile, the COPD Foundation educates on managing incurable COPD, and Tezspire connects patients with specialists for severe asthma care.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI."Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.